Charles River Laboratories International

Charles River Laboratories, Inc., is a corporation specializing in a variety of pre-clinical and clinical laboratory services for the pharmaceutical, medical device, and biotechnology industries. The Company also supplies assorted biomedical products and research and development outsourcing services for use in the pharmaceutical industry. Charles River Laboratories' customers include pharmaceutical and biotechnology companies as well as academic institutions and government research centers. 

Company Growth (employees)
Type
Public
HQ
Wilmington, US
Founded
1947
Size (employees)
11,000 (est)+28%
Website
criver.com
Charles River Laboratories International was founded in 1947 and is headquartered in Wilmington, US

Charles River Laboratories International Office Locations

Charles River Laboratories International has an office in Wilmington
Wilmington, US (HQ)
251 Ballardvale Street

Charles River Laboratories International Data and Metrics

Charles River Laboratories International Financial Metrics

Charles River Laboratories International's revenue was reported to be $445.8 m in Q1, 2018
USD

Revenue (Q1, 2018)

445.8 m

Gross profit (Q1, 2018)

378.5 m

Gross profit margin (Q1, 2018), %

85%

Net income (Q1, 2018)

47 m

EBIT (Q1, 2018)

69.5 m

Market capitalization (21-Sep-2017)

5 b

Cash (01-Apr-2017)

131.5 m
Charles River Laboratories International's current market capitalization is $5 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

1.2 b1.3 b1.4 b1.7 b

Revenue growth, %

11%5%23%

Cost of goods sold

264 m277 m

Gross profit

1.1 b1.4 b
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2018

Revenue

341.2 m327.6 m320.4 m339.6 m349.5 m354.9 m434.1 m425.7 m445.8 m

Cost of goods sold

67.6 m65.2 m64.4 m62.6 m66.2 m66.8 m68.2 m69.3 m67.2 m

Gross profit

273.6 m262.3 m256 m276.9 m283.2 m288.1 m365.9 m356.4 m378.5 m

Gross profit Margin, %

80%80%80%82%81%81%84%84%85%
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

155.9 m160 m117.9 m117.6 m

Accounts Receivable

220.6 m258 m270.1 m364.1 m

Inventories

89.4 m89 m93.7 m95.8 m

Current Assets

552.6 m606.9 m559.2 m656.8 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2018

Cash

117 m130.7 m151.9 m150.8 m74 m157.4 m154.6 m105.7 m131.5 m

Accounts Receivable

274.5 m275 m265.4 m277.4 m288.8 m287.2 m345.5 m359.7 m383.7 m

Inventories

92.6 m92.7 m86.1 m90 m98.1 m97.1 m98.1 m99.4 m98.5 m

Current Assets

592.7 m606 m614.1 m629.6 m578.7 m637.4 m701.5 m654.6 m700.1 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

104.2 m128.2 m151.1 m156.4 m

Depreciation and Amortization

96.6 m96.4 m24.2 m41.7 m

Accounts Receivable

(17 m)(52.8 m)

Inventories

(1.6 m)(3 m)3.4 m(4 m)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2018

Net Income

35.8 m32.4 m31.6 m49.2 m37.9 m37.5 m35.6 m38 m47 m

Depreciation and Amortization

5.3 m5.7 m6.4 m6.4 m11.2 m11.8 m10.7 m

Accounts Receivable

277.4 m288.8 m287.2 m345.5 m359.7 m383.7 m

Inventories

90 m98.1 m97.1 m98.1 m99.4 m98.5 m
Y, 2017

Financial Leverage

3.1 x
Show all financial metrics

Charles River Laboratories International Market Value History

Traffic Overview of Charles River Laboratories International

Charles River Laboratories International Online and Social Media Presence

Charles River Laboratories International News and Updates

BRIEF-Charles River Labs Q2 earnings per share $0.73

Aug 3 (Reuters) - Charles River Laboratories International Inc

Charles River Laboratories International Company Life and Culture

You may also be interested in